Status:
COMPLETED
Stage I/II NSCLC Perioperative Chemotherapy
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Conditions:
Non-small Cell Lung Cancer Stage I and II
Peri-operative Chemotherapy
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The addition of chemotherapy to lung cancer surgery is now considered as the standard of care. Solid data support postoperative chemotherapy but only few results are available in the preoperative sett...
Detailed Description
In this multicenter study, patients are randomized to receive either two preoperative chemotherapy cycles plus two additional preoperative cycles if they respond to chemotherapy, or two preoperative p...
Eligibility Criteria
Inclusion
- Histologically or cytologically NSCLC stade I or II Resectable disease WHO performance status of 2 or less
Exclusion
- NSCLC stage III or IV
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
530 Patients enrolled
Trial Details
Trial ID
NCT00198354
Start Date
May 1 2001
End Date
December 1 2010
Last Update
March 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Besancon - Pneumologie
Besançon, France, 25000